[Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
作者信息
Jantke J, Schwartzkopff W, Zschiedrich M
出版信息
Verh Dtsch Ges Inn Med. 1977;83:392-5.
PMID:206057
Abstract
摘要
相似文献
1
2
3
Gemfibrozil treatment: a comparison with clofibrate.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):88-9. doi: 10.1177/00359157760690S222.
4
Does hypolipidemic therapy prevent coronary heart disease?
Cardiovasc Clin. 1974;6(2):1-8.
5
Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Postgrad Med J. 1975;51(8):suppl 66-71.
6
7
[Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
MMW Munch Med Wochenschr. 1975 Oct 31;117(44):1783-6.
8
Treatment of hyperlipidemia.
N Engl J Med. 1974 Jun 6;290(23):1295-301. doi: 10.1056/NEJM197406062902306.
9
[Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
MMW Munch Med Wochenschr. 1977 May 20;119(20):701-4.
10
[Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
MMW Munch Med Wochenschr. 1976 Sep 3;118(36):1127-30.
Zotero 插件